Status:
COMPLETED
Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder
Lead Sponsor:
NYU Langone Health
Conditions:
Cigarette Smoking
Addiction
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Patients in addiction treatment have exceptionally higher rate of cigarette smoking and very low quit rates compared to the general population. The purpose of this study is to examine the feasibility ...
Detailed Description
Electronic nicotine delivery devices often referred to as e-cigarettes, are battery-powered devices that deliver vaporized nicotine when inhaled. Corresponding with the growth in media attention, mark...
Eligibility Criteria
Inclusion
- smokes at least 10 cigarettes per day
- meet DSM-V AUD and/or OUD within the past year, interested in reducing CPDs
- able to provide consent
- use a cell phone, are willing/able to receive and respond to daily text messages regarding their cigarette use and e-cigarette use on their cell phone
- provide one additional contact, and are willing to use an e-cigarette for 3 weeks.
Exclusion
- pregnant and/or breast feeding (self-reported)
- currently using smoking cessation medications (including other forms of NRT, buproprion, or varenicline)
- enrolled in a smoking cessation program or another cessation tria
- have used an e-cigarette in the past 14 days
- have used any other tobacco products (pipe, cigar, cigarillos, snuff, chewing tobacco, rolling tobacco, or hookah/shisha) in the past 30 days
- report having a history of asthma, other airways diseases, or heart disease.
Key Trial Info
Start Date :
October 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04063267
Start Date
October 27 2020
End Date
June 30 2024
Last Update
December 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016